⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TBPH News
Theravance Biopharma, Inc.
Theravance Biopharma to Participate in Upcoming Investor Conferences
prnewswire.com
TBPH
Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
prnewswire.com
TBPH
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
prnewswire.com
TBPH
Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
prnewswire.com
TBPH
Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy
businesswire.com
TBPH
Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting
prnewswire.com
TBPH
Theravance Biopharma Completes Enrollment in Pivotal Phase 3 CYPRESS Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension due to Multiple System Atrophy
prnewswire.com
TBPH